News
Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...
Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...
In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...
9d
New Scientist on MSNDrugs like Ozempic and Wegovy could significantly cut dementia riskDozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...
20h
Verywell Health on MSN4 Foods to Avoid and 3 You Should Eat While Taking OzempicCertain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.
As semaglutide-based weight loss treatments such as Ozempic and Wegovy become more popular, new side effects are emerging – ...
Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...
Novo Nordisk said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a ...
Novo Nordisk’s Vikrant Shrotriya on accelerating Wegovy’s launch, pricing strategy, and building long-term obesity care ...
People taking GLP-1s consumed less processed food, although they still craved it. As a growing number of people using ...
Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results